Prezista News
Most Popular Prezista Story
Gilead inks one combo HIV drug pact as it explores new ties with J&J
HIV powerhouse Gilead and Johnson & Johnson's Tibotec subsidiary are joining forces on a combo HIV treatment. Under a new pact Gilead will combine its new boosting agent cobicistat with J&J's Read more...
Latest Headlines
- November 16, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
